OFAC SDNCriticalEntity

REEM PHARMACEUTICAL

🇱🇧Lebanon21564

FEOC Flagged

REEM PHARMACEUTICAL appears on 2 critical federal lists. Equipment, services, or transactions involving this entity likely fail FEOC requirements for IRA tax credits (45X, 48E, 30D).

Critical findings

  • OFAC SDNSpecially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.
  • UFLPA Entity ListEntities using forced labor from Xinjiang. Goods are presumptively excluded from U.S. import per the Uyghur Forced Labor Prevention Act.
Risk Summary
List severityHighOn 2 critical lists
Country riskLowLebanon (non-covered)
Ownership transparencyHighNot in global LEI registry — opacity flag
Parent exposureMediumNo parent data
Cross-list countMedium2 federal lists

Relationships at a glance

3 nodes · 2 relationships · open Network tab for full view

Federal-list cross-reference

This entity name appears on 2 federal lists.

OFAC SDNTreasury OFAC

Specially Designated Nationals list. Strict financial sanctions — U.S. persons are generally prohibited from dealing with these entities.

Listed as: REEM PHARMACEUTICAL#21564
Source
UFLPA Entity ListDHS / FLETF

Entities using forced labor from Xinjiang. Goods are presumptively excluded from U.S. import per the Uyghur Forced Labor Prevention Act.

Listed as: Sichuan Yuan’an Pharmaceutical Co., Ltd.Since 2024-11-24#us-uflpa-078c88b2493b38c5192ae2636c25b6778980e04b
Source

Relationship graph

3 nodes · 2 relationships

Click any node to open its source. Federal lists at top, primary entity in center, parents and curated profile below.

Also known as

REEM PHARMACEUTICAL, S.A.R.L.REEM PHARMACEUTICAL, LLCREEM PHARMACEUTICAL, SAL

Known addresses

  • Kalim Bechara Building, 2nd floor, Trabolsi Street, Badaro, Beirut, Lebanon

Sanctions programs / authorities

SDGT] [IRGC] [IFSR

Sanctioning authority notes

Website www.reempharma.com; Additional Sanctions Information - Subject to Secondary Sanctions; Secondary sanctions risk: section 1(b) of Executive Order 13224, as amended by Executive Order 13886.

Data sources

  • OFAC SDN · Treasury OFACsource
  • UFLPA Entity List · DHS / FLETF · listed 2024-11-24source
Raw record (for audit / legal review)
{
  "source_list": "OFAC_SDN",
  "source_record_id": "21564",
  "source_url": "https://ofac.treasury.gov/specially-designated-nationals-list-data-formats-data-schemas",
  "citation": "Treasury OFAC SDN entry 21564",
  "entity_name": "REEM PHARMACEUTICAL",
  "entity_type": "Entity",
  "country": "Lebanon",
  "aliases": [
    "REEM PHARMACEUTICAL, S.A.R.L.",
    "REEM PHARMACEUTICAL, LLC",
    "REEM PHARMACEUTICAL, SAL"
  ],
  "addresses": [
    "Kalim Bechara Building, 2nd floor, Trabolsi Street, Badaro, Beirut, Lebanon"
  ],
  "programs": [
    "SDGT] [IRGC] [IFSR"
  ],
  "date_added": null,
  "raw_data": {
    "grt": "-0- ",
    "title": "-0- ",
    "ent_num": "21564",
    "program": "SDGT] [IRGC] [IFSR",
    "remarks": "Website www.reempharma.com; Additional Sanctions Information - Subject to Secondary Sanctions; Secondary sanctions risk: section 1(b) of Executive Order 13224, as amended by Executive Order 13886.",
    "tonnage": "-0- ",
    "sdn_name": "REEM PHARMACEUTICAL",
    "sdn_type": "-0- ",
    "call_sign": "-0- ",
    "vess_flag": "-0- ",
    "vess_type": "-0- ",
    "vess_owner": "-0- "
  }
}

Informational only — not legal advice. Cross-list matching is name-based; verify identity with the source authority before procurement or compliance decisions.